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toreandplaya role in heattfailure,coronaryheartdisease,andpulmonary
hypertension(PHT). In vitro studiesshowedthat ET I is releasedfrom
culturedendothelialcellsduringhypoxemia.Obstruefivesleepapnoeasyn-
drome(OSAS)is associatedwith hypoxemiathat altersthe cardiovascular
system.Aimof ourstudywasto provewhetherhypoxemiain manstimulates
releaseof ET L Methods.’In 10 malepatients(pts.;meanage 57.9 + 5.5
y), we meSSUred the circulatingET l-, AT H-,Norepinephrine-(NEPI), and
Epinephrina-(EPI)levelstakenfroman antecubitalveinat 4 occasions:8
pm(Rest)end5 amafterthediagnostic(Diag.)night,and5 amaffertherapy
I (Ther.1)andtherapyII (Ther.11)night.DuringTher.IandIIpts.weretreatad
withCPAP.Respiratorydisturbanceindex(RDI)andoxygendeesturationin-
dex(ODI)weredeterminedduringDiag.,Ther.I andII bypolysomnogrephy.
Resu/fe:ETI andATII weresignificantlyelevatedafterDiag.,anddropped
significantlyafterTher.I and II parallelto a significantdecreaseof RDIand
ODI.NEPIandEPIshowednosignificantchanges.
Rest Diaa. Ther. I Thor. II
RDI n/h 6t.09+21.77 25.93+ 19.t4# 8.33& 8.44~
ODI nfh 57.56 + 23.2S 19.85 + 18.01# 5,19 * 3.635
ET I {pmolfl) 0.98 +0.9S 0673+ 7.16’ 0.88 & 0.76# 0.49+ 0.65$
AT II {nmoljl) 12.48 + 1.49 15.40 + 2.61* 12.98* 1.99# 12.03+ 1.409
values are mesns + SD; “p <0.05 Rest vs Diag.;#p <0.05 Ther. I vs Diag.; 5p <0.05
Ther. II vs Diag.
Conclusion:1. Releaseof ETI istriggeredbyhypoxemiaandATH-levels
areelevatedinpts.withOSAS.2.AdequatetreatmentwithCPAPresultsina
significantdropof ETI andATII Inpts.withOSAS.3. ElevatedET1-andAT
H-levelscouldbemediatorsin thedevelopmentof PHTinpts.withOSAS.
11052-151] PreservedPulmonarvVasodilatorCa~acitvin
~ PatientsWithPrimerj PuimonaryHypsttsnsion
Meaeuredby LoceiVesodiietorApplication
C.Opitz,F.Krackhardt,R.Wensel,G.Baumann,F.X.Kleber.Departmentof
Medicine,Chaiit4,Berlin,Germany
Dueto a variableinfluenceof closingpressureonpulmonatyvascularresis-
tance,the responseof pulmonaryresistancevesselsto variousvasodilators
is bestmeasuredunderstabledrivingpressuresand cardiacoutput.This
wasaccomplishedby meaauringlocalflow velocityin a pulmona~artery
branch.
Weinvestigated10patientswithprimarypulmonawhypertension(mean
pulmonaryarterypressure54* 22rnmHg,meanpulmonatyC=apillavwedge
pressure12* 9 mmHg,pulmonawvascularresistance13+ 8 WoodUnits).
Bioodflow veloeitywas measuredwith a flow wire (0.018”)positioned
in a pulmonaryarterybranchwith a diameterof 3-6 mm as determined
by intravascularultrasound.Drug infusionewereadjustedto providelocal
concentrationsof 10-6-10-4 M Acetylcholine(max.2.5 mglmin),3.12.5-
50.0ng/mi/secProefaglandinEI (max. 8.5 &@kg/min)in the targetvessel,
0.125-1.0@/k@minsodiumnitroprussideand5 mgNifedipintmlus.
Achcauseda significantdose-dependentincreasein bloodflowveioc-
ity withoutmncomitantchangesin pulmonaryor systemichemodynamics
(table).
A flOWVelOCity Responder> 20%) ACardiacoutput
Acarvkholina 12s% i 31%”* 9/10 –0.57 Vmin............
Nlfedipin 56”A+ 1l”A* 5/5 +0.66 Vmin
PGE1 47% * 15% 5/6 +1.12 !Jmin
SNP 31% * 10% 419 +0.50 lrmin
mean + SEM, *p c 0.05, l*p c 0.01
Ourinvestigationdemonstratesapresewadendothelialreceptor-mediated
vasedilatorresponsein patientswithprimarypulmonaryhypertension.This
responseissuperiorto theeffectsof directvasodilatore.
m1052152 Effectaofthe EndotheiinAntegoniatBosentan
afterintravenousAdministrationonCoronary
andSyetemicHemodynamicsin Patientewith
CoronaryArteryDisease
R.R.Wenzel,G.Neil,M. Fleisch,U.Kaufmann,B.Meier,R.Schmitt’,
R.Jones1,M.Clozel T.F.Lk.cher.CardiologyUrriversityHospita/Bem,
Switzerland,1Hoi$mann-LaRoche,Base\,Switzerland
EndothelinplasmaIeveisare elevatedin atherosclerosis,in myocardialin-
farctionand in acutecoronarysyndromes.Toelucidatethe effectsandthe
safetyof endothelinantagonistsin patientswith Coronawarterydisease
(CAD),we performeda double-blind,placebo-controlledrandomizedstudy,
where200mgbosentsnorpiacebowasinfusedintravenouslyover15minin
30patientswithasignifieentstenosisofoneormorecoronaryvessels.Blood
pressure(BP),heatlrate(HR),coronarybloodflow(CBF),coronarydiameter
(CD)beforeand40 minutesafteradministrationof thedrugwereassessed.
CBFwasmeasuredwitha Dopplerguidewire(Flowire”,Cardiometrics)post-
stenotieelly,CDwasassessadbyquantitativecoronayangiogrsphyandBP
wasmeasuredintraarterially(aorta).Corona~flow resewe(CFR)wasas-
sessedwithintrecoronaryadenosine(12or 18#g).
Resuk All patientshadan impairedCFR(< 2.0, n.s.vs placebo).No
seriousadverseeventswereobservedafterinfusionof bosentan;2 ptshada
transient asymptomatic hypotension, 3 patientshadanginapeetoris(1 in the
bosentan-group,2 in the placebo-group).BosentanreducedsystolicBP (p
<0.05 after30rein),whileFreatiratedid notchange.CDtendedto increase
afterbosentan(+0.1+ 0.1 mm,n.s.vs placebo).Despitethe decreasein
blood pressureand the slight increasein CD, CBFdid not changeafter
bosentan(n.s.vscontrol).IncreasesinCDcorrelatedinverselywithplasma
LDL4evels(# = 0.56,p < 0.01),
ConcbsiorxBoeentanis safein patientswithstablecoronaryarterydis-
easeandinspiteof a BPloweringeffecttendsto increaseCBF.Changesin
CDinverselycorrelatewithLDL-cholesterol.Hence,furthertrialswill deter-
minethe effectsof the drugwithprolongedtreatmentand in subgroupsof
CADpatients.
-] kIIprOvedEndoti’teiialFunctionis Associated
withCurrentbutnotPastEstrogenUeein
—
PostmenopausalWomen
L.R.Peterson, M. Courtois, R.Spina,V.G.DWila-Rom6n,S. Barzilai.
WashingtonUnht,St.Louis,MO,USA
Short-termestrogenadminiatrstionimprovesvasomotortoneinpostmenopausal
women,butthevasomotoreffectsofcurrentandpaationg-termoralestrogen
replacementtherapy(ERT)havenotbeanthoroughlystudied.Wetherefore
useda I=er Dopplerdevieeto evaluatemeanforearmcspiliarybloodflowat
baseline,duringa2-minutebrschialocclusion(OCCL),andatpeakbloedflow
duringthe pestleehemichyperemicresponse(HYP)in a totaiof 61 healthy
premenopausal(PREMENO)and postmenopausalwomen.Basellneskin
temperatureand bloodpressuredid not differ in postmenopausalwomen
whohadnevertakenERT(NEVER),thoseon ERTin the past (off ERT>
1 month)(PAST),andthosecurrentlytakinglong-termERT(LONG-TERM).
Forearmcepiilatybloodflow (mean + SD)weeas follows:
Capillay BloodFlow (rluxunits)
n Baseline OCCL HYP
PREMENO 21 13,6+ 3.5 4.6 + 1.1 73.4* we
LONG-TERM 18 17.6+ S.6 3.9 + 1.7 80.9+22.2
NEVER 14 12.9* 3,3 4.1 * 2.0 53.6& 17.0”
PAST 6 13.2+ 4.6 4.4 i 1.5 56.4 k 15.4t
‘p< 0.02; tp <0.001 bothvecsuaLONG-TERM HYP;
Thepeakhyperemicresponsein womenon long-termERTdid notdiffer
from premenopausalwomen.There was a significantdifferencein peak
hyperemicresponseinpostmenopausalwomenonlong-termERTcompsrad
tothatinpostmenopausaiwomenwhohadnevertekenERT.Womenonlong-
termERThada greaterpeakresponsethanthosewho hadtakenit in the
past.Thus,continueduseof long-termoralERTisassoeiatadwithincreaead
endothelialreactivityin postmenopausalwomen:endotheiiaireactivityin
postmenopausalwomenon ERTis notdifferentfromthat in premenopeueai
women,whereasthat in postmenopausalwomenwho had usad ERTbut
stoppadis relativelydecreased.
110~2-1541 Endotheiium-indepandentVasodiiationls
impairedinPatientswithHypercalcemia
T.Neunteufl,R.Katzenschlager,C.Abela,A. Haseen,B. Niaderle,
F.Weidinger,T.Stefenelii.UniversifyofVienna,Austria
Patientswithhypercelcemiareat increasedriskfor prematuredeathfrom
ischemicheartdiseaseand stroke.Moreover,the heart is a target organ
for intactparathyroidhormone(iPTH).Thisstudywasperformedto testthe
Infiuenceof hyperceicemiandelevatediPTHaerumievelsonendetheliurn-
dependent,flow-mediatadvasodilation(FMD)andendothelium-indepandent,
nitroglycerin-inducedilation (NMD).Methods:Twenty-fourpatientswith
PHPT(mean& SD;age55 + 15,serumcaiciurn3.0* 0.3 mmoi/L,iPTH
225* 160pg/mL,serumphosphate0.77+ 0.21mmoVL)andnoevidenceof
coronaryarterydisease(CAD)aswellas30normoealcemicpatientswithout
evidenceof CAD(Non-CAD;age 50 + 13)werestudied.Afterwithdrawal
of all vseoactivemedicationfor at ieast24 h vasodilationfollowingreaetive
hyperemia ndafterO.8mgnitroglycerinwereaeeessadinthebrachiaiattery
by usinghighresolutionultrasound(7 MHz).Re.suk NMDwas impairedin
PHPTptsmmpsredtotheNon-CADcontrols(11.7+ 4.2%vs.15.9& 8.0°4;
p < 0.05).FMDwasnotsignificantlydifferentinPHPTpatientsandNon-CAD
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controls (12.8 + .5.3~o vs. 12.6 * 6.77.; NS). Univariate analysis within the
PHPT group revealed aeignificent inverse correlation between NMD and the
calcium-phosphate product (p= 0.037, r = –0.49). Conclusion: Endothelium-
independent vasodilation is impaired in patients with PHPT compared to
normocalcemic controls without CAD, while endothelium-dependent dilation
was similar in both study groups. Thus, altered arterial reactivity in the course
of PHPT may predominantly involve the media and not theendothelium as
observed previously in patients with varioua stages of atherosclerosis.
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m105313 RenalArteryStentPlacement:ClinicalUtilityintheTreatmentof RenalArteryStenosie
C.J. White, S.R. Ramea, T.J. Collins, J.S. Jenkins, A. Escobar, D. Shaw.
HCIMedicalCentre,Glasgow,UK,OchsnerClinic,NewOrfeans,Louisiana,
USA
The purpose of this study waato assessthe safety and efficacy of renal artery
stant placement for renal artery stenoses. Balloon expandable stents were
placed in 100 consecutive patients (P) (133 renal arteries) with hypetienaion
and renal artery stenosis. Indications for stent placement included aorto-
ostial lesion location in 80.5% (n = 107), a suboptimal balloon angioplasfy
(PTA) result in 12% (n = 16), or reatenosis lesions in 7.5% (n = 10). Bilateral
stents were placed in 33 P and unilateral stents in 67.P, of whom 5 had a
aolifery kidney treated. Angiogrephic succeaawas obtained in 99Y0(132/133)
of the lesions. Clinical succesa was achieved in 76% of the P. Six months
following stent placement, the systolic blood praasure was reduced from 173
& 25 mmHg to 147 + 23 mmHg (p -= 0.001); the diaatolic pressure from
S6 + 17 mmHg to 76 + 12 mmHg (p < 0.001), and the mean number of
antihypefiensive medications per P from 2.6 * 1 to 2.0 + 0.9 (p < 0.001). In
44 P with chronic renal insufficiency, tha pre-procedure creatinine (Cr) was
2.4 + 1.6 mg/dL and the post procedure Cr was not significantly changed at
2.5 + 1.8 mgfdL (p = 0.59). Angiographic follow-up at 8.7 + 5.0 months in 67
P revealed reatenosis (> 50% diameter narrowing) in 16.8% (15/60) of the
stanted vessels. Conclusion:Renal artery stanting is an effective treatment
for renovascular hypertension with a low angiographic restenosis rate. Stent
placement is a very attractive alternative to surgical revaecularization for
renovascular hypertension in P with unattractive Iasions for PTA such as
ostial lesions, restepotic lesions, and following a suboptimal PTAprocedure.
m105314 ArterielStiffnessAccompaniedNon-DipperHypertensive
E.A. Karpanou, N. Kafaltis, C. Malakou, A. Psichogios, A. Benetoe,
D.V. Cokkinos. OnassisCardiacSurgeryCenteLAthens,Greece
.Many studiea have ahown that left ventricular hypertrophy and increased
arterial atiffness are more common in hypertensive patients with impaired
blood pressure variability (non-dipper+ Complior, is a validated automatic
machine for meaauring carotid-femoral pulse wave velocity (PWV), as the
ratio of the distance between carotid and femoral artery over the time delay of
thepulsewave upatroke (PW) respectively.Toassees the relation of impaired
aortic distensibility aa indicated by increased PWV to hypertension severity,
57 patients with esaential hypertension were studied. They were without
medications and those with coronary arIery dieeaae, diabetes mellitus, and
claudicetion were excluded. They all underwent 24-hour ambulatory blood
pressure monitoring with Simultaneous recording of PWV. Twenty petients
were classified as dippers and 37 as non-dippers. Nocturnal systolic blood
pressure (SBP) and diastolic blood preasure (DBP) were higher in non
dippera (131 vs 119p= 0.0009) and 75 vs 68 mmHg (p= 0.03). PWV was
higher (14.4 va 11.3mdsecp < 0.0001) while it was related to24-hour SBP (r
= 0.41, p = 0.003) daytime SBP (r = 0.33, p = 0.01) and especially nighttime
SBP (r=O.64 p < 0.0001). Similar correlations were obsewd between PWV
and DBP in 24 hour (r = 0.57, p < 0.0001) daytime (r= O.q, p =0.0001) and
night-tima (r= 0.76, p < 0.0001).
it is concluded that nondipper hypertensives have impaired arterial com-
pliance and increased PWV. BP is positively related to PWV, especially at
night.
RelationshipBetween24-hrAmbulatoryBlood
PreasureandLargeAtterieaCompliance
D.A. Duprez, M.L. De Buyzere, B.B. Drieghe, D.L. Clement, C. Chesney,
S.M. Finkelstein 1,J.N. Cohn 1. UrriversiiyHospifa/Gent,Be/giurn,
1UniVefSifyof Minnesota,USA
Increased blood pressure level induces target organ damage not only at
the left ventricle (LV) but also at the large arteries leading to decreased
arterial compliance. Ambulatory blood pressure (ABP) is better mrrelated
than office BP with LV mass, but its relationship to arterial compliance has
not been documented. Arterial compliance can be assessed either globally
for major parts of the arterial tree or Ibcally for aegments of large arteries.
We enrolled 33 aubjects (17 males, 16 females, age 49 + 16 yeare) covering
a large BP range from 60 to 134 mmHg diaatolic and from 110 to 250 mmHg
aystolic and simultaneously measured proximal arterial compliance Cl of
the aortaand major side branches and C2 of the distal part of the arterial
circulation (radial artery pulse wave contour analysis) aa well as the cross-
sectionai compliance CC of the common carotid artery (echo wall tracking).
Mean 24 hr systolic (S) and diastolic (D) BP were 139 + 14 mmHg and 63
+ 9 mmHg. Mean proximal and distal compliance respectively were 1.55 +
0.48 and 0.052 + 0.02 ml/mmHg, while mean common carotid artery (CC)
was 7.7 + 2.610-7 m21kPa.
Systolic and diastolic ABP are aignificently correlated with Cl’, while
systolic ABP is only borderline correlated with CC and C2.
cl C2 cc
24JwSBPr= -0.53, p = 0.002 r= –0.33,p = 0.07 r = –0.32,p= 0.0S
24hrDBPr= -0.51. D= 0.003 NS NS
In conclusion, arterial compliance of the aorta and major aide branches
correlates invereeiy with mean ambulatory blood pressure.
/1053-16] lnfluen=ofblood p~esaureonprogressionof
cerebralinfarction
T. Sugiyama, J.-D. Lee, H. Shimizu, T. Ueda, S. Abel. FulruiMedical
School,Fukui,Japan,1AbeHospital,Ohno,Japan
PurposeandMetfmds:To examine whether the treatment for hypertenaiva
patiants does prevent the progression of silent cerebral infarction, we ob-
tained the magnetic resonance imaging (MRI) repeatedly at mean interval
of 26 months in 107 Japanese subjects aged 35 to 69 (mean 72 yeare),
including 24 nonvalvular atrial fibrillation patienta (Af), 24 sinus bradycerdia
(Brady) and 39 hypertensive petienta (HT). Since the patients were receiving
various agents, blood preaaure of each patient wee monitored periodically
during the observation period. Depending on the average blood pressure at
the end of follow-up period, patients were classified into 3 groups: normoten-
sion (NT), borderline(BHT) and hypertension (HT). None had prior history
of symptomatic cerebral infarction and neurological abnormalities. Number
of infarcted lesions were determined on brain MRI by two independent ob-
servers.
Results: SCI Ieaionawere observed in 47 subjects (44%) on enrollment.
The incraased number of infarcted lesiona were found in 18 subjects in NT
(n= 51, 35%), 18 in BHT (n = 41, 46%) and 10 in HT (n = 15, 67%). In the
patients with Af, infarcted lesions were increased independently from BP (NT
= 42%, BHT = 44%, HT = 33%). In the patients with sinus bradycerdia, a
vigorous control of BP seems to be rether harmful (NT= 67%, BHT = 40%,
HT = 100%). In contrast, in hypertensive patients, blood presaure controlled
to the normal level appeara to result in the lower incidence of the progression
of infarcted area (NT= 33%, BHT = 59%, HT = 57%).
Conclusion.’Our data indicate that an appropriate anti-hypetienaive traat-
ment prevents the occurrence of cerebral infarction in hypertensive patients.
m105317 ArterielPressureWsveReflectionandLeftVentricularDiastolicFunction
A. Ganau, P.S. Sabe, R. Pini, C. Longhini2, M.J. Roman3,
R.B. Devereux3. C/inice/Medicine,Saeeari,Italy 1GerontologyFlorence,
/ta/y,2krfernalMedicine,Ferrara,Italy 3CornellMedicalCenteLNewYork,
USA
Experimental data show that abrupt changes in Ikwd condition during Iaft
ventricular (LV) ejection modify LV relaxation. In the presence of elevated
aortic stiffnesa, pulse wave velocity (PWV) increaaes and the backward prea-
aure waves originating at the periphery of the arteriai tree by reflection of the
primary arterial pressure waves may reach the left ventricle in aystole and
increase LV contraction or relaxation load. To asseaa whether early pres-
sure wave reflection affects LV diastolic function, we investigated relations
of PWV, intensity and timing of the reflected pressure wavea with indices of
LV relaxation and filiing. We studied 20 healthy subjecte (age 2*76 years)
